Note 8 - Accrued Expenses and Other Current Liabilities

9 Months Ended

Sep. 30, 2024

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

8. Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	September 30,		December 31,
	2024		2023
Compensation and related expenses	$	10,500	$	11,828
Professional fees		3,449		3,240
Operating lease liability – current		2,292		2,133
Stock-based compensation		1,624		-
Clinical trial costs		363		460
Income taxes payable		82		1,240
Discontinuation of software development project		-		1,904
Other		378		394
Total	$	18,688	$	21,199